EUVIMEDEUVIMED entdecken
Open Access

Malignant undifferentiated epithelioid neoplasms with MAML2 rearrangements: A clinicopathologic study of seven cases demonstrating a heterogenous entity

Josephine K Dermawan iD, Sara E DiNapoli, Purvil Sukhadia, Kerry A Mullaney, Rebecca Gladdy, John H Healey, Abbas Agaimy, Arjen H Cleven, Albert J H Suurmeijer, Brendan C Dickson iD, Cristina R Antonescu

Genes, Chromosomes and Cancer · 2023

DOI: 10.1002/gcc.23102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, Chromosomes and Cancer, 2023. Verfasst von Josephine K Dermawan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Fibrosarcoma, Soft Tissue Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Among mesenchymal tumors, MAML2 gene rearrangements have been described in a subset of composite hemangioendothelioma and myxoinflammatory fibroblastic sarcoma (MIFS). However, we have recently encountered MAML2‐ related fusions in a group of seven undifferentiated malignant epithelioid neoplasms that do not fit well to any established pathologic entities. The patients included five males and two female, aged 41–71 years old (median 65 years). The tumors involved the deep soft tissue of extremities (hip, knee, arm, hand), abdominal wall, and the retroperitoneum. Microscopically, the tumors consisted of solid sheets of atypical epithelioid to histiocytoid cells with abundant cytoplasm. Prominent mitotic activity and necrosis were present in 4 cases. In 3 cases, the cells displayed hyperchromatic nuclei or conspicuous macronucleoli, and were admixed with background histiocytoid cells and a lymphoplasmacytic infiltrate. By immunohistochemistry (IHC), the neoplastic cells had a nonspecific phenotype. On targeted RNA sequencing, MAML2 was the 3′ partner and fused to YAP1 (4 cases), ARHGAP42 (2 cases), and ENDOD1 (1 case). Two cases with YAP1::MAML2 harbored concurrent RAF kinase fusions ( RBMS3::RAF1 and AGK::BRAF , respectively). In 2 cases with targeted DNA sequencing, mutations in TP53 , RB1 and PTEN were detected in 1 case, and PDGFRB mutations, CCNE1 amplifications and CDKN2A/2B deletion were detected in another case, which showed strong and diffuse PDGFRB expression by IHC. Of the 4 cases with detailed clinical history (median follow‐up period 8 months), three developed distant metastatic disease (one of which died of disease); one case remained free of disease 3 years following surgical excision. In conclusion, we describe a heterogeneous series of MAML2 ‐rearranged undifferentiated malignant epithelioid neoplasms, a subset of which may overlap with a recently described MIFS variant with YAP1::MAML2 fusions, further expanding the clinicopathologic spectrum of mesenchymal neoplasms with recurrent MAML2 gene rearrangements.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibrosarcomaSoft Tissue NeoplasmsMaleHumansFemaleReceptor, Platelet-Derived Growth Factor betaBiomarkers, TumorGene RearrangementTranscription FactorsTrans-Activators

Stichwörter der Autor:innen

MAML2YAP1epithelioidmyxoinflammatory fibroblastic sarcomaundifferentiated sarcoma

Substanzen

Receptor, Platelet-Derived Growth Factor betaBiomarkers, TumorTranscription FactorsMAML2 protein, humanTrans-Activators

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Surgery, Sinai Health System, Toronto, Ontario, Canada.
  • Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Institute of Pathology, Erlangen University Hospital, Comprehensive Cancer Center, European Metropolitan Area Erlangen-Nuremberg, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
  • Department of Pathology, University Medical Center Groningen, Groningen, The Netherlands.
  • Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.

ORCID-Profile: Josephine K Dermawan, Brendan C Dickson

Förderung

  • NCI NIH HHS

Zitieren

APA

Dermawan, J. K., DiNapoli, S. E., Sukhadia, P., Mullaney, K. A., Gladdy, R., Healey, J. H., Agaimy, A., Cleven, A. H., Suurmeijer, A. J. H., Dickson, B. C., & Antonescu, C. R. (2023). Malignant undifferentiated epithelioid neoplasms with MAML2 rearrangements: A clinicopathologic study of seven cases demonstrating a heterogenous entity. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.23102

Vancouver

Dermawan JK, DiNapoli SE, Sukhadia P, Mullaney KA, Gladdy R, Healey JH, et al. Malignant undifferentiated epithelioid neoplasms with MAML2 rearrangements: A clinicopathologic study of seven cases demonstrating a heterogenous entity. Genes, Chromosomes and Cancer. 2023. doi:10.1002/gcc.23102

BibTeX
@article{Dermawan2023,
  author = {Dermawan, Josephine K and DiNapoli, Sara E and Sukhadia, Purvil and Mullaney, Kerry A and Gladdy, Rebecca and Healey, John H and Agaimy, Abbas and Cleven, Arjen H and Suurmeijer, Albert J H and Dickson, Brendan C and Antonescu, Cristina R},
  title = {Malignant undifferentiated epithelioid neoplasms with MAML2 rearrangements: A clinicopathologic study of seven cases demonstrating a heterogenous entity},
  journal = {Genes, Chromosomes and Cancer},
  year = {2023},
  doi = {10.1002/gcc.23102}
}
Kostenlos starten →